###begin article-title 0
###xml 150 158 <span type="species:ncbi:9606">Patients</span>
Influence of Adiponectin Gene Polymorphisms on Adiponectin Level and Insulin Resistance Index in Response to Dietary Intervention in Overweight-Obese Patients With Impaired Fasting Glucose or Newly Diagnosed Type 2 Diabetes
###end article-title 0
###begin p 1
H.K.C. and J.S.C. contributed equally to this work.
###end p 1
###begin title 2
OBJECTIVE
###end title 2
###begin p 3
The aim of this study was to determine the effect of common adiponectin gene polymorphisms on dietary intervention-mediated changes in adiponectin levels and homeostasis model assessment of insulin resistance (HOMA-IR) indexes.
###end p 3
###begin title 4
RESEARCH DESIGN AND METHODS
###end title 4
###begin p 5
###xml 158 162 <span type="species:ncbi:4530">rice</span>
A total of 363 subjects with impaired fasting glucose (IFG) or newly diagnosed type 2 diabetes followed a dietary intervention (replacement of cooked refined rice with whole grains and an increase in vegetable intake) and regular walking for 12 weeks without any medication. Adiponectin gene single nucleotide polymorphisms (SNPs) (45, 276, and -11377) were examined in these subjects.
###end p 5
###begin title 6
RESULTS
###end title 6
###begin p 7
After this dietary intervention, fasting glucose levels decreased in all three SNP 45T>G genotype groups. Subjects with the SNP 45TT genotype showed increased adiponectin levels and decreased HOMA-IR indexes. Haplotype analysis revealed that homozygous carriers of the TG haplotype (45TT and 276GG) and heterozygous carriers of the TG haplotype (TG/X) showed a reduction in the HOMA-IR index after adjustment for baseline levels. Significant differences were observed in changes in HOMA-IR indexes and adiponectin concentrations according to the 45-276 TG haplotype in overweight-obese, but not in normal-weight subjects: the greatest decrease in HOMA-IR indexes and the greatest increase in adiponectin levels were shown in overweight-obese subjects with the TG/TG haplotype.
###end p 7
###begin title 8
CONCLUSIONS
###end title 8
###begin p 9
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
ADIPOQ genetic variants can affect circulating adiponectin levels and insulin resistance indexes in subjects with IFG or newly diagnosed type 2 diabetes in response to dietary intervention.
###end p 9
###begin p 10
###xml 130 136 130 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
###xml 162 163 162 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 267 268 267 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 325 331 325 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
###xml 422 423 422 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 423 423 423 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4"/>
###xml 424 425 424 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 459 460 459 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 489 495 489 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
###xml 916 917 916 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
Adiponectin is a protein produced and secreted by adipocytes that influences the body's response to insulin. It is encoded by the ADIPOQ gene on chromosome 3q27 (1) in a region previously identified through genetic linkage studies as a diabetes susceptibility locus (2). Several single nucleotide polymorphisms (SNPs) in the ADIPOQ gene have been shown in Japanese and European populations to be associated with diabetes (3-5) or insulin resistance syndrome (6). However, previous work on ADIPOQ SNPs have shown that the SNPs associated with type 2 diabetes or circulating adiponectin levels differ according to both the study cited and the ethnic population studied. Specifically, SNPs 276G>T (intron 2) and 45T>G (exon 2) have been associated with various levels of adiponectin as well as BMI, fasting insulin concentration, and homeostasis model assessment of insulin resistance (HOMA-IR) in nondiabetic Koreans (7).
###end p 10
###begin p 11
###xml 132 133 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 347 348 347 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 407 413 407 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
###xml 655 656 655 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 726 728 726 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1066 1068 1066 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 222 228 <span type="species:ncbi:9606">humans</span>
###xml 239 245 <span type="species:ncbi:9606">humans</span>
###xml 821 825 <span type="species:ncbi:4530">rice</span>
###xml 955 959 <span type="species:ncbi:4530">rice</span>
###xml 1156 1160 <span type="species:ncbi:4530">rice</span>
Circulating levels of adiponectin are unlikely to be affected by acute dietary changes but rather reflect dietary intake over time (8). However, little is known about the dietary modulation of plasma adiponectin levels in humans. Although humans differ in their responses to diet and many of these differences can be due to genetic polymorphisms (9,10), the majority of previous studies have considered the ADIPOQ gene only in relation to the degree of insulin resistance syndrome without considering responses to dietary intervention. Recently, a carbohydrate-rich diet with a high glycemic load was found to be associated with lower adiponectin levels (8). According to the 2005 Korean National Health and Nutrition Survey (11), carbohydrate-derived calories account for 64% of total caloric intake, and cooked refined rice is the major source of carbohydrates in middle-aged adults. Because of this high carbohydrate intake, the replacement of refined rice with whole grains and legumes has been suggested as a way to reduce the risk factors for type 2 diabetes (12). Therefore, we determined the effects of dietary intervention (replacement of refined rice with whole grains, a high intake of vegetables, and regular exercise) on circulating adiponectin levels and insulin resistance indexes in conjunction with common adiponectin gene polymorphisms in Koreans with impaired fasting glucose (IFG) or newly diagnosed type 2 diabetes.
###end p 11
###begin title 12
RESEARCH DESIGN AND METHODS
###end title 12
###begin p 13
###xml 34 46 <span type="species:ncbi:9606">participants</span>
Study subjects were selected from participants in a nutrition genomic study conducted by the National Research Laboratory of Clinical Nutrigenetics/Nutrigenomics (Program R0A-2005-000-10144-0) at Yonsei University. Study subjects were recruited from the Health Service Center or the outpatient clinics at Yonsei University Severance Hospital in Seoul, Korea, and National Health Insurance Corporation Ilsan Hospital in Goyang, Korea.
###end p 13
###begin p 14
###xml 200 201 200 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 359 360 357 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</italic>
###xml 392 393 390 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 429 430 427 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</italic>
###xml 478 479 476 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</italic>
###xml 549 550 545 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</italic>
###xml 628 640 <span type="species:ncbi:9606">participants</span>
Subjects with a diagnosis of type 2 diabetes or IFG who consented to the dietary intervention program were included. Hyperglycemia was defined according to the American Diabetes Association criteria (9), in which diabetes is defined as fasting glucose >/=126 mg/dl, and IFG is defined as fasting glucose between 100 and 125 mg/dl. Exclusion criteria included 1) previous history of diabetes, 2) abnormal liver or renal function, 3) history of cardiovascular disease and cancer, 4) unstable weight loss/gain (>/=2 kg) over the previous 6 months, and 5) thyroid or pituitary disease. A total of 430 Koreans were recruited, and 67 participants discontinued the study for personal reasons. Finally, 363 subjects completed the study program. All subjects gave their written informed consent for the study, which was approved by the Institutional Review Board of Yonsei University.
###end p 14
###begin p 15
###xml 39 45 39 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
###xml 130 131 130 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
Detailed methods for the genotyping of ADIPOQ SNPs (-11377, 45, and 276) and clinical laboratory tests were described previously (7).
###end p 15
###begin title 16
Dietary intervention program and assessment of dietary intake/physical activity level
###end title 16
###begin p 17
###xml 498 502 <span type="species:ncbi:4530">rice</span>
A 12-week dietary intervention program was conducted. The subjects' usual diets were assessed using a semiquantitative food frequency questionnaire and a 24-h recall method at baseline. All subjects were given written and verbal instructions by a registered dietitian on how to complete a 3-day dietary record every 4 weeks. Individualized and nutritionally balanced diets were planned for each subject at the initial visit. The dietary intervention program consisted of the replacement of refined rice with whole grains three times a day as a carbohydrate source and an increase in vegetable intake to at least 6 units (30-70 g/unit) per day for sufficient dietary fiber intake. The subjects were told to drink no more than one alcoholic beverage drink (15 g alcohol) per day and were assigned physical activity, comprising a regular 30-min walk after dinner each day.
###end p 17
###begin p 18
The energy values and nutrient content of dietary intake were calculated using the Computer Aided Nutritional Analysis Program (CAN-Pro 2.0, Korean Nutrition Society). Total energy expenditures were calculated from activity patterns including basal metabolic rate (by the Harris-Benedict equation), physical activity for 24 h, and the specific dynamic action of food.
###end p 18
###begin title 19
Statistical analysis
###end title 19
###begin p 20
###xml 307 308 307 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 992 993 992 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Hardy-Weinberg equilibrium, linkage disequilibrium (LD), and haplotype frequencies were determined by Haploview (version 3.32; ), and subject-specific haplotypes were estimated using the HapAnalyzer program () with the EM algorithm. We also used SPSS (version 12.0 for Windows; SPSS, Chicago, IL). A paired t test was used to evaluate the effect of dietary intervention. ANOVA with the Bonfer-roni method or a general linear model was used to test the genotype or haplotype effects. Pearson and partial correlation coefficients were used to examine the relationship between adiponectin levels and other metabolic variables. Finally, a multiple linear regression analysis was performed to find independent effects on changes in adiponectin levels after dietary intervention. Each variable was examined for normal distribution, and the skewed variables were tested after logarithmic transformation. For descriptive purposes, mean values are presented on untransformed and unadjusted variables. P < 0.05 was considered statistically significant.
###end p 20
###begin title 21
RESULTS
###end title 21
###begin title 22
###xml 16 22 16 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
###xml 53 54 53 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
Distribution of ADIPOQ SNPs in the study population (n = 363)
###end title 22
###begin p 23
###xml 45 46 45 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 385 386 385 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 451 452 451 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 530 531 530 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 903 904 903 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 956 957 956 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 992 993 992 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
All SNPs were in Hardy-Weinberg equilibrium (P > 0.05). SNP -11377 contained 56.5% C/C, 36.6% C/G, and 6.9% G/G (C frequency = 0.748). SNP 45 contained 49.3% T/T, 41.9% T/G, and 8.8% G/G (T frequency = 0.703). SNP 276 contained 52.3% G/G, 39.4% G/T, and 8.3% T/T (G frequency = 0.720). LD was calculated between the three SNPs: low LD between SNP +45T>G and SNP -11377C>G (D' = 0.692; P < 0.001) and between SNP +276G>T and SNP -11377C>G (D' = 0.003, P = 0.092) and complete, strong LD between SNP +45T>G and SNP +276G>T (D' = 1; P < 0.001). Accordingly, haplotype analysis was performed for SNP 45T>G combined with SNP 276G>T. Estimated 45-276 haplotype frequencies were 17.8% for TG/TG, 22.8% for TG/TT, 25.7% for TG/GG, 8.1% for TT/TT, 16.3% for TT/GG, and 9.2% for GG/GG. In subsequent statistical analyses, subjects were divided into three haplotype groups: homozygous for the TG haplotype (TG/TG; n = 65) and heterozygous for the TG haplotype (TG/X; n = 177) and non-TG haplotype (X/X; n = 121).
###end p 23
###begin title 24
Clinical characteristics and nutrient intake both before and after dietary intervention.
###end title 24
###begin p 25
###xml 194 201 194 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 631 638 631 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 550 562 <span type="species:ncbi:9606">participants</span>
The 12-week dietary intervention increased HDL cholesterol but significantly decreased blood pressure and serum concentrations of glucose, triglycerides, total cholesterol, and LDL cholesterol (Table 1). Adiponectin levels were slightly but not significantly higher after dietary treatment. There were significant increases from baseline in both fiber intake and the polyunsaturated fatty acids-to-saturated fatty acids ratio and a slight increase in total energy expenditure but a decrease in total energy intake. The mean body weights of the study participants were slightly but significantly reduced after dietary intervention (Table 1).
###end p 25
###begin p 26
Effects of a 12-week dietary intervention on anthropometric and biochemical markers
###end p 26
###begin p 27
###xml 23 24 21 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
Data are means +/- SE. n = 363.
###end p 27
###begin p 28
###xml 18 19 18 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
*Tested by paired t test.
###end p 28
###begin p 29
daggerTested by logarithmic transformation.
###end p 29
###begin p 30
double daggerHOMA-IR = (fasting insulin [microunits per milliliter] x fasting glucose [millimoles per liter])/22.5. PUFA/SFA, polyunsaturated fatty acids-to-saturated fatty acids ratio.
###end p 30
###begin title 31
###xml 79 85 79 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
Baseline characteristics, adiponectin levels, and HOMA-IR indexes according to ADIPOQ SNP genotypes
###end title 31
###begin p 32
###xml 105 112 105 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 124 131 124 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 430 437 430 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 569 576 569 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
There were no significant differences in terms of sex distribution, age, and BMI associated with SNP 45 (Table 2), SNP 276 (Table 2), and SNP -11377 (data not shown) genotypes. At baseline, we did not observe any significant genotype-related associations between the three SNPs and plasma adiponectin levels. However, for SNP 276, baseline serum glucose levels were significantly higher in GG subjects than in TG and TT subjects (Table 2). For the 45T>G/276G>T haplotypes, TG/TG subjects showed higher insulin levels and HOMA-IR indexes than did non-TG subjects (X/X) (Table 2).
###end p 32
###begin p 33
Effects of ADIPOQ SNP 45 and SNP 276 on insulin resistance indices and plasma adiponectin levels before and after dietary treatment
###end p 33
###begin p 34
###xml 24 25 22 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
Data are means +/- SEM. n = 363.
###end p 34
###begin p 35
*Tested by logarithmic transformation.
###end p 35
###begin p 36
###xml 6 7 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
daggerP < 0.05;
###end p 36
###begin p 37
###xml 12 13 2 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
daggerdaggerP < 0.01;
###end p 37
###begin p 38
###xml 18 19 3 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 111 112 96 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
daggerdaggerdaggerP < 0.001 compared with baseline values in each genotype or haplotype group tested by paired t test;
###end p 38
###begin p 39
###xml 13 14 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
double daggerP < 0.05 compared with wild-type and
###end p 39
###begin p 40
###xml 12 13 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
section signP < 0.05 compared with heterozygotes tested by ANOVA with the Bonferroni method.
###end p 40
###begin p 41
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
aP = 0.239 after adjustment for baseline glucose;
###end p 41
###begin p 42
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
bP = 0.074 after adjustment for baseline HOMA-IR;
###end p 42
###begin p 43
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
cP = 0.005 after adjustment for baseline insulin;
###end p 43
###begin p 44
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
dP = 0.008 after adjustment for baseline HOMA-IR.
###end p 44
###begin title 45
###xml 98 104 98 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
Effect of a 12-week dietary intervention on HOMA-IR indexes and adiponectin levels in relation to ADIPOQ SNP genotype
###end title 45
###begin p 46
###xml 160 167 160 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 437 438 434 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 466 467 463 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 502 503 499 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Regardless of the SNP 45T>G genotype, the dietary intervention significantly decreased serum glucose levels without any significant increase in insulin levels (Table 2). After the dietary intervention, HOMA-IR indexes were reduced in subjects carrying the SNP 45T allele. SNP 45TT subjects also had a mean adiponectin level increase of 0.48 +/- 0.17 mug/ml (10.9%). There was a significant genotype-related difference in insulin levels (P = 0.005), HOMA-IR indexes (P = 0.049), and adiponectin levels (P = 0.037) for SNP 45.
###end p 46
###begin p 47
###xml 157 164 157 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 250 251 250 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 336 337 336 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
After the 12-week trial, serum glucose levels were reduced in subjects carrying the SNP 276G allele, and HOMA-IR indexes were reduced in SNP 276GG subjects (Table 2). There was initially a significant decrease in HOMA-IR indexes among the genotypes (P = 0.025), but this difference disappeared after adjustment for the baseline levels (P = 0.074).
###end p 47
###begin p 48
###xml 34 41 34 41 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 332 333 332 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 364 365 364 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 451 452 451 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 475 476 475 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 592 593 592 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
In the 45-276 haplotype analysis (Table 2) after the 12-week trial, serum glucose levels were significantly decreased in all haplotype groups. However, HOMA-IR indexes were reduced only in subjects carrying the TG haplotypes (TG/TG + TG/X) but not in the non-TG subjects (X/X). There were significant differences in insulin levels (P < 0.001) and HOMA-IR indexes (P < 0.001) regarding the 45-276 haplotype, even after adjustment for baseline insulin (P = 0.005) and HOMA-IR (P = 0.008). We also found haplotype-related differences for 45T>G/276G>T regarding the change in adiponectin levels (P = 0.03). TG/TG subjects had a mean adiponectin increase of 0.71 +/- 0.35 mug/ml (16.3%) after the 12-week trial, whereas X/X subjects showed a mean adiponectin decrease of -0.19 +/- 0.21 mug/ml (3.8%).
###end p 48
###begin title 49
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
Effect of the ADIPOQ 45-276 haplotype on HOMA-IR indexes and adiponectin levels in response to the 12-week dietary intervention in relation to BMI
###end title 49
###begin p 50
###xml 96 97 96 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 125 126 125 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 412 413 407 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 471 472 461 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 529 530 515 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
The subjects were divided into two subgroups according to individual BMI values, either <25 kg/m2 (normal-weight) or >25 kg/m2 (overweight-obese). We evaluated the effects of BMI on changes in HOMA-IR indexes and plasma adiponectin levels in association with the 45-276 haplotype. As expected, the two BMI subgroups differed significantly in baseline values of adiponectin (5.1 +/- 0.26 vs. 4.4 +/- 0.25 mug/ml, P < 0.05), insulin (8.2 +/- 0.32 vs. 11.4 +/- 0.50 muU/ml, P < 0.001), and HOMA-IR (2.67 +/- 0.12 vs. 3.65 +/- 0.17, P < 0.001); however, no significant difference was found in glucose levels (133 +/- 2.2 vs. 130 +/- 2.3 mg/dl).
###end p 50
###begin p 51
###xml 201 207 201 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 404 405 398 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 416 422 410 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 761 762 749 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 817 818 805 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 908 909 896 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1340 1346 1322 1328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
In the normal-weight subgroup, there were no significant differences in either baseline or change values for HOMA-IR and adiponectin after dietary intervention among the three 45-276 haplotype groups (Fig. 1). However, in the overweight-obese group, TG haplotype carriers had significantly higher baseline HOMA-IR values than non-TG carriers (TG/TG 4.2 +/- 0.45, TG/X 3.9 +/- 0.24, and X/X 2.9 +/- 0.27, P = 0.009) (Fig. 1). After dietary intervention, HOMA-IR indexes were significantly reduced in overweight-obese subjects with the TG/TG haplotype, but not with either the TG/X or the X/X haplotype. A significant difference was observed in HOMA-IR indexes according to the 45-276 haplotypes (TG/TG -1.05 +/- 0.31, TG/X -0.43 +/- 0.19, and X/X 0.46 +/- 0.26, P = 0.001), even after adjustment for baseline HOMA-IR (P = 0.017). We also found haplotype-related differences for changes in adiponectin levels (P = 0.017). After dietary intervention, overweight-obese subjects with the TG/TG haplotype had a mean adiponectin increase of 1.09 +/- 0.61 mug/ml (26.2%), whereas those with the X/X haplotype had a mean adiponectin decrease of -0.33 +/- 0.28 mug/ml (7.9%). In addition, circulating adiponectin levels after the 12-week program in the overweight-obese subjects with the TG haplotype were higher than those in non-TG carriers (X/X) (Fig. 1).
###end p 51
###begin p 52
###xml 126 132 121 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
###xml 174 175 169 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 192 193 187 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 229 230 224 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 260 261 255 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 276 277 266 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 302 303 282 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 382 383 362 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 390 390 370 370 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="zdc004097503001a.jpg" mimetype="image"/>
###xml 390 391 370 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 438 439 418 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
HOMA-IR indexes and circulating adiponectin levels before (square) and after (■) dietary treatment and mean changes sorted by ADIPOQ 45T>G/276G>T haplotype according to BMI (A: normal-weight; B: overweight-obese). P1, unadjusted P value; P2, baseline-adjusted P value. dagger P < 0.05 and daggerdagger P < 0.01 compared with baseline values in each haplotype group tested by paired t test. P < 0.05 compared with the TG/TGhaplotype and * P < 0.05 compared with the TG/X haplotype tested by ANOVA with the Bonferroni method.
###end p 52
###begin p 53
###xml 100 106 100 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
###xml 333 339 333 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
###xml 386 387 383 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 451 452 445 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 520 521 511 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 591 592 579 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 812 813 797 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 863 869 848 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
###xml 912 913 894 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Finally, a multiple linear regression analysis was performed to find the independent effects of the ADIPOQ 45-276 haplotype as well as sex, age, BMI, baseline values of glucose, insulin, and adiponectin and change values of glucose, insulin, and adiponectin in the total group and subgroups according to BMI. In the total group, the ADIPOQ 45-276 haplotype (standardized beta = -0.154, P = 0.025), baseline insulin levels (standardized beta = -0.188, P = 0.041), baseline adiponectin levels (standardized beta = -0.159, P = 0.034), and changes of insulin levels (standardized beta = -0.200, P = 0.018) showed independent effects on adiponectin levels after dietary intervention. In a subgroup analysis, changes in adiponectin levels were affected by only baseline adiponectin levels (standardized beta = -0.372, P < 0.001) in the normal-weight group and only the ADIPOQ polymorphism (standardized beta = -0.214, P = 0.033) in the overweight-obese group.
###end p 53
###begin title 54
Relationship between changes in plasma adiponectin level and metabolic parameters
###end title 54
###begin p 55
###xml 103 104 103 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 114 115 114 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 138 139 138 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 149 150 149 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 339 340 339 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 350 351 350 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 445 446 445 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 456 457 456 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 499 500 499 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 510 511 510 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Overall, changes in adiponectin levels were negatively correlated with changes in both insulin levels (r = -0.16, P = 0.022) and HOMA-IR (r = -0.15, P = 0.028) after adjustment for age, sex, and changes in body weight. After adjustments for those, changes in adiponectin levels were negatively correlated with baseline adiponectin levels (r = -0.32, P = 0.001) in normal-weight subjects and negatively correlated with changes in insulin levels (r = -0.20, P = 0.044) and changes in HOMA-IR indexes (r = -0.23, P = 0.020) in overweight-obese subjects.
###end p 55
###begin title 56
CONCLUSIONS
###end title 56
###begin p 57
###xml 80 86 80 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 317 323 317 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
###xml 428 436 <span type="species:ncbi:9606">patients</span>
The most relevant finding from our study is that the genetic variability at the ADIPOQ locus influences the ability of dietary intervention to alter insulin resistance as measured by HOMA-IR indexes in subjects with IFG or newly diagnosed type 2 diabetes. Similarly, Kang et al. (13) reported on the role of specific ADIPOQ variants in modulating interindividual differences in the response to drug treatment in type 2 diabetic patients.
###end p 57
###begin p 58
###xml 18 24 18 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
###xml 466 467 466 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 468 469 468 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 565 571 565 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
###xml 713 714 713 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 715 717 715 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
We examined three ADIPOQ SNPs that had previously been suggested to affect HOMA-IR: 45T>G, 276G>T, and -11377C>G. For the -11377C>G SNP, we found no genotype-dependent differences in HOMA-IR indexes and adiponectin levels in response to dietary intervention. Although previous findings have suggested that SNPs -11391 and -11377 are associated with adiponectin levels and contribute to the development of type 2 diabetes, these studies were performed in Caucasians (3,5). Thus, the discrepancy may be explained by ethnic differences. In fact, the -11391 SNP at the ADIPOQ promoter region was monomorphic in this study population (G:A = 1:0), and it is also not found in either the Japanese or Chinese population (4,14).
###end p 58
###begin p 59
###xml 260 266 260 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 853 855 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
Fasting serum glucose levels were decreased in all three SNP 45T>G genotypes after dietary intervention. However, subjects with the SNP 45TT genotype had an increase in adiponectin levels and a decrease in HOMA-IR indexes. Similarly, in haplotype analysis for ADIPOQ 45T>G/276G>T, subjects with the TG/TG haplotype had a 21% decrease in HOMA-IR indexes and a greater increase in adiponectin levels after dietary intervention. Zacharova et al. (15) also found that the SNP 45G allele predicts the conversion to type 2 diabetes in subjects with impaired glucose tolerance despite regular exercise and either a weight-reducing or a weight-maintaining diet. Furthermore, the combined effects of the 45G allele and the 276T allele on the conversion from impaired glucose tolerance to type 2 diabetes were observed to be stronger than that of each SNP alone (15).
###end p 59
###begin p 60
###xml 243 244 243 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 1086 1092 1085 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
BMI is another factor in the response to dietary intervention. At baseline, the high HOMA-IR index observed among subjects with the TG/TG haplotype was only seen in the overweight-obese subgroup. This result is in accordance with Jang et al. (7) who found an association between the TG haplotype and increased HOMA-IR index in overweight-obese but not in normal-weight nondiabetic Koreans. In response to dietary intervention, overweight-obese subjects carrying the TG/TG haplotype exhibited an increase in adiponectin levels (1.09 mug/ml) and a 25% decrease in HOMA-IR index. This finding might indicate that a genotypic-specific effect is heightened in overweight-obese individuals in terms of altered adiponectin levels and HOMA-IR index after dietary intervention compared with normal-weight individuals. However, these results must be interpreted with caution. They do not mean that normal-weight subjects have a relatively poor outcome after dietary intervention compared with overweight-obese subjects. Moreover, it remains unclear whether adiponectin levels change according to ADIPOQ SNPs and whether this change is clinically relevant for long-term dietary intervention programs.
###end p 60
###begin p 61
###xml 62 68 62 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
###xml 87 88 87 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 89 90 89 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 853 855 849 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 856 858 852 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
Even though several reports have shown an interaction between ADIPOQ SNPs and obesity (5,8,16), the mechanism is not yet known. One possible explanation might be that obesity with increased adipose tissue predispose individuals to altered adipocytokine levels (e.g., decreased adiponectin and increased tumor necrosis factor-alpha) and, thus, the effect of the adiponectin gene is more exaggerated in obesity. Another possibility is that lower baseline adiponectin levels in obesity might induce additional changes in adiponectin levels and amplify the diet-intervention effect. Indeed, a multiple regression analysis in this study showed that baseline adiponectin levels were independent factors to determine changes in adiponectin levels. Also, there are several reports to suggest the relationship between adiponectin levels and treatment responses (17,18). However, further experimental studies are needed to clarify the mechanism underlying these responses.
###end p 61
###begin p 62
###xml 72 74 72 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 341 343 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 905 907 903 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 908 910 906 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
Small differences in adiponectin levels can have clinical significance (19). Our findings that a small increase in adiponectin (1.09 mug/ml) along with a decrease in both fasting insulin and glucose levels in overweight-obese subjects carrying the TG/TG haplotype confirm a previous report of the insulin-sensitizing effects of adiponectin (19). In the TG/TG haplotype group, the insulin-sensitizing effects of adiponectin compensate for insulin and result in a decreased demand for insulin and improvement in the insulin resistance index. This hypothesis might be supported by the observation that overweight-obese subjects carrying non-TG alleles showed a decrease in adiponectin levels (0.33 mug/ml) and a slight, although insignificant, increase in HOMA-IR indexes. Thus, we also observed an inverse relationship between changes in HOMA-IR indexes and adiponectin levels similar to previous findings (18,20).
###end p 62
###begin p 63
###xml 16 18 16 18 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
Fumeron et al. (21) found that variations at the adiponectin locus affect body weight gain, onset of hyperglycemia, and adiponectin levels in a 3-year prospective study in French Caucasians. Specifically, GG carriers of SNP 45T>G were found to gain more weight and have a higher risk of hyperglycemia. In this study, however, 45GG subjects or subjects who did not carry the TG haplotype of 45T>G/276G>T showed no significant changes in body weight, fasting glucose and insulin levels, HOMA-IR indexes, or adiponectin levels either before or after dietary intervention. This discrepancy might be due to either the ethnic specificity or the short-term effects of dietary changes.
###end p 63
###begin p 64
###xml 53 55 53 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 114 120 114 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
###xml 219 220 215 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 695 703 <span type="species:ncbi:9606">patients</span>
There is also a conflicting report by Nelson et al. (22) in which adiponectin levels are altered independently of ADIPOQ polymorphisms after dietary supplementation with alpha-linolenic acid. Because small sample size (n = 57) in the previous study cannot allow interpretation of the genetic effect, a possible assumption can be made that specific effects of dietary factors (i.e., high omega-3 fatty acids) can mask the genetic effects in relatively insulin-sensitive healthy subjects. In addition, direct comparisons between studies are difficult, considering the differences in the characteristics of the subjects studied (healthy, young, primarily female, and Caucasian versus hyperglycemic patients, middle-aged, fewer female, and Korean) and study intervention program.
###end p 64
###begin p 65
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 733 741 <span type="species:ncbi:9606">patients</span>
There are several limitations in our study design that should be mentioned. First, dietary intake was based on self-reports obtained from weighed food. However, measurement errors from self-reported dietary intake and lifestyle variables have been shown to be relatively small (23). In this study, well-controlled, fasting glucose concentrations reflected the compliance of the subjects to dietary intervention. Second, because of the small sample size, the results of genetic analyses should be interpreted with caution. Finally, heterogeneity in the causes of predisposition to diabetes and diabetes itself must be considered because metabolic differences can be present between subjects with IFG and type 2 diabetes. However, our patients with newly diagnosed type 2 diabetes did not show different metabolic characteristics, including plasma adiponectin levels, compared with those in subjects with IFG (data not shown). Further additional studies with a larger sample size are needed to confirm our findings.
###end p 65
###begin p 66
###xml 42 48 42 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
###xml 423 429 423 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
###xml 213 221 <span type="species:ncbi:9606">patients</span>
Despite these limitations, we showed that ADIPOQ genetic variants can be factors in the interindividual differences in adiponectin levels and insulin resistance indexes after dietary intervention in hyperglycemic patients. We found the greatest decrease in HOMA-IR indexes and greatest increase in adiponectin levels in overweight-obese subjects with IFG or newly diagnosed type 2 diabetes who carry the TG/TG haplotype of ADIPOQ 45T>G/276G>T. However, long-term prospective studies are needed to examine the relationship between adiponectin levels and clinical outcomes in these subjects. With a more complete understanding of these factors, our results provide good evidence for tailoring of dietary intervention programs to individuals on the basis of their genetic patterns.
###end p 66
###begin p 67
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 67
###begin title 68
Acknowledgments
###end title 68
###begin p 69
We acknowledge the support of the National Research Laboratory (Project R0A-2005-000-10144-0), Ministry of Science and Technology, Seoul, Korea; Korea Science and Engineering Foundation (Grant M10642120002-06N4212-00210), Ministry of Science and Technology, Seoul, Korea; Korea Health 21 R&D Projects, Ministry of Health and Welfare (A000385), Seoul, Korea.
###end p 69
###begin p 70
No potential conflicts of interest relevant to this article were reported.
###end p 70
###begin title 71
REFERENCES
###end title 71
###begin article-title 72
Genomic structure and mutations in adipose-specific gene, adiponectin.
###end article-title 72
###begin article-title 73
Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24.
###end article-title 73
###begin article-title 74
Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians.
###end article-title 74
###begin article-title 75
Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population.
###end article-title 75
###begin article-title 76
Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish Caucasians.
###end article-title 76
###begin article-title 77
A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome.
###end article-title 77
###begin article-title 78
###xml 128 133 <span type="species:ncbi:9606">women</span>
The influence of the adiponectin gene on adiponectin concentrations and parameters of metabolic syndrome in non-diabetic Korean women.
###end article-title 78
###begin article-title 79
###xml 77 80 <span type="species:ncbi:9606">men</span>
Association between dietary factors and plasma adiponectin concentrations in men.
###end article-title 79
###begin article-title 80
Diagnosis and classification of diabetes mellitus.
###end article-title 80
###begin article-title 81
Standards of medical care in diabetes-2008.
###end article-title 81
###begin article-title 82
The Third Korea National Health and Nutrition Examination Survey (KNHANES III).
###end article-title 82
###begin article-title 83
###xml 131 139 <span type="species:ncbi:9606">patients</span>
Consumption of whole grain and legume powder reduces insulin demand, lipid peroxidation, and plasma homocysteine concentrations in patients with coronary artery disease: randomized controlled clinical trial.
###end article-title 83
###begin article-title 84
###xml 80 88 <span type="species:ncbi:9606">patients</span>
The influence of adiponectin gene polymorphism on the rosiglitazone response in patients with type 2 diabetes.
###end article-title 84
###begin article-title 85
Polymorphisms of the gene encoding adiponectin and glycaemic outcome of Chinese subjects with impaired glucose tolerance: a 5-year follow-up study.
###end article-title 85
###begin article-title 86
The common polymorphisms (single nucleotide polymorphism [SNP] +45 and SNP +276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
###end article-title 86
###begin article-title 87
Adiponectin SNP276 is associated with obesity, the metabolic syndrome, and diabetes in the elderly.
###end article-title 87
###begin article-title 88
###xml 106 112 <span type="species:ncbi:9606">humans</span>
Serum adiponectin levels predict the effect of short-term dietary interventions on insulin sensitivity in humans.
###end article-title 88
###begin article-title 89
Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects.
###end article-title 89
###begin article-title 90
###xml 92 100 <span type="species:ncbi:9606">patients</span>
Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.
###end article-title 90
###begin article-title 91
The association of SNP276G>T at adiponectin gene with circulating adiponectin and insulin resistance in response to mild weight loss.
###end article-title 91
###begin article-title 92
Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the Insulin Resistance Syndrome Prospective Study.
###end article-title 92
###begin article-title 93
Adiponectin levels are reduced, independent of polymorphisms in the adiponectin gene, after supplementation with alpha-linolenic acid among healthy adults.
###end article-title 93
###begin article-title 94
Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals.
###end article-title 94

